Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Revance Therapeutics, Inc. (RVNC)
|
|
| Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Long-term debt | 380.3 | 379.9 | 378.9 | 378.4 | 378.0 | 280.6 | 280.3 | 280.0 |
| Total debt | 380.3 | 379.9 | 378.9 | 378.4 | 378.0 | 280.6 | 280.3 | 280.0 |
| Net debt | 60.6 | 105.9 | 0.3 | 144.6 | 115.4 | 55.6 | 6.6 | |
| |
| |
|